The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Print

Morning Seminar

MS3-4

The future of CML therapeutic strategy -when TFR (treatment-free remission) is an option in clinical practice-

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Chiaki Nakaseko (Department of Hematology, International University of Health and Welfare School of Medicine)

Sponsor: Novartis Pharma K.K.